The accumulation of 99m Tc-labeled probes targeting saturable systems of the body is hindered by the presence of a large excess of unlabeled ligands needed to ensure high radiochemical yields in a short reaction time. To address the issue, we recently reported a novel concept of a metal-coordinationmediated synthesis of a bivalent 99m Tc-labeled probe from a monovalent ligand using D-penicillamine (Pen) as a chelating molecule and c(RGDfK) as a model targeting device. The Pen-conjugated c(RGDfK) via a hexanoate linkage (Pen-Hx-c(RGDfK)) provided a bivalent [ 99m Tc]Tc-[(Pen-Hx-c(RGDfK)) 2 that possessed much higher integrin α v β 3 binding affinity than Pen-Hx-c(RGDfK) and visualized a murine tumor without purification. However, high radioactivity levels were observed in the abdominal regions, which necessitated improved pharmacokinetics of the probes for practical applications. In this study, a pharmacokinetic (PK) modifier was introduced to manipulate the pharmacokinetics of the 99m Tc-Pen 2 -based bivalent probe. The Hx linkage in Pen-Hx-c(RGDfK) was replaced with acetyl-D-serine-D-serineglycine (Ac-ssG) or hexanoyl-D-serine-D-serine-D-serine (Hx-sss) to prepare Pen-Ac-ssG-c(RGDfK) or Pen-Hx-sss-c(RGDfK). Pen-Ac-ssG-c(RGDfK) impaired the complexation ability of Pen-Hx-c(RGDfK), and a monovalent 99m Tc-labeled compound was generated at low ligand concentration. However, Pen-Hx-sss-c(RGDfK) provided the objective bivalent 99m Tc-labeled probe in high radiochemical yields at a concentration similar to that of Pen-Hx-c(RGDfK). [ 99m Tc]Tc-[Pen-Hx-sss-c(RGDfK)] 2 also possessed stability and integrin α v β 3 binding affinity similar to those of [ 99m Tc]Tc-[Pen-Hx-c(RGDfK)] 2 . As a result, [ 99m Tc]Tc-[Pen-Hx-sssc(RGDfK)] 2 exhibited tumor and abdominal radioactivity levels similar to and significantly lower than those of [ 99m Tc]Tc-[Pen-Hxc(RGDfK)] 2 . These findings indicate the incorporation of a tripeptide PK modifier to Pen-Hx-c(RGDfK) preserved the complexation ability and improved the pharmacokinetics of the resulting 99m Tc-labeled bivalent probe without impairing the targeting ability. Thus, the [Pen-Hx-(PK modifier)-(targeting device)] would constitute a basic formulation for preparing the 99m Tc-Pen 2 -based bivalent probes for imaging saturable targets of the body.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.